{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T07:11:17Z","timestamp":1791529877001,"version":"4.3.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1918,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>Drug-induced autoimmune hepatitis (DIAIH) has been reported to be caused by several drugs. There is a lack of data comparing these patients with other patients with autoimmune hepatitis (AIH). A search was performed using the Mayo Clinic diagnostic medical index for AIH patients and DIAIH patients identified over 10 years. Individuals with overlap syndromes and decompensated liver disease were excluded. Overall, 261 patients (204 females, median age 52) were identified, and 24 (9.2%) were DIAIH cases with a median age of 53 (interquartile range, 24-61). Two drugs, nitrofurantoin (n = 11) and minocycline (n = 11), were the main causes. A similar proportion of DIAIH patients had positive antinuclear antibodies (83% versus 70%) and smooth muscle antibodies (50% versus 45%) as compared with AIH patients. Histological grade and stage were similar in patients with DIAIH versus AIH; however, none of the DIAIH patients had cirrhosis at baseline; this was present in 20% of matched AIH cases. Liver imaging was normal in all minocycline cases. Eight of 11 (73%) nitrofurantoin patients had abnormalities on hepatic imaging (mainly liver atrophy), a finding seen in only 8 of 33 (24%) of a random sample of the rest of the AIH group (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>= 0.0089). Corticosteroid responsiveness was similar in DIAIH and the AIH patients. Discontinuation of immunosuppression was tried and successful in 14 DIAIH cases, with no relapses (0%), whereas 65% of the AIH patients had a relapse after discontinuation of immunosuppression (<\/jats:bold>\n                                 <jats:bold>\n                                    P\n                                 <\/jats:bold>\n                                 <jats:bold>&lt; 0.0001).<\/jats:bold>\n                                 <jats:bold>\n                                    Conclusion:\n                                 <\/jats:bold>\n                                 <jats:bold>A significant proportion of patients with AIH have drug-induced AIH, mainly because of nitrofurantoin and minocycline. These two groups have similar clinical and histological patterns. However, DIAIH patients do not seem to require long-term immunosuppressive therapy. (Hepatology 2010;)<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.23588","type":"journal-article","created":{"date-parts":[[2010,4,30]],"date-time":"2010-04-30T19:38:45Z","timestamp":1272656325000},"page":"2040-2048","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":434,"title":["Drug-Induced Autoimmune Hepatitis: Clinical Characteristics and Prognosis"],"prefix":"10.1097","volume":"51","author":[{"given":"Einar","family":"Bj\u00f6rnsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Talwalkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sombat","family":"Treeprasertsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Schuyler","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Neuhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Lindor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20250312","doi-asserted-by":"crossref","first-page":"10541066","DOI":"10.1002\/hep.510260438","article-title":"Cytochromes P450 and uridine triphosphateglucuronosyltransferases: model autoantigens to study druginduced, virusinduced, and autoimmune liver disease.","volume":"26","author":"Manns","year":"1997","journal-title":"HEPATOLOGY"},{"key":"R2-21-20250312","doi-asserted-by":"crossref","first-page":"755774","DOI":"10.1016\/S1089-3261(02)00025-9","article-title":"Immunemediated druginduced liver disease.","volume":"6","author":"Liu","year":"2002","journal-title":"Clin Liver Dis"},{"key":"R4-21-20250312","doi-asserted-by":"crossref","first-page":"641645","DOI":"10.1111\/j.1749-6632.1993.tb35929.x","article-title":"Autoantibodies against cytochromes P450 in druginduced autoimmune hepatitis.","volume":"685","author":"Beaune","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"RU6-21-20250312","doi-asserted-by":"crossref","first-page":"12871295","DOI":"10.1016\/S0026-895X(25)10602-0","article-title":"Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anticytochrome P4501A2 autoantibodies.","volume":"45","author":"Bourdi","year":"1994","journal-title":"Mol Pharmacol"},{"key":"R7-21-20250312","doi-asserted-by":"crossref","first-page":"326333","DOI":"10.1016\/S0026-895X(25)09234-X","article-title":"Tienilic acidinduced autoimmune hepatitis: antiliver andkidney microsomal type 2 autoantibodies recognize a threesite conformational epitope on cytochrome P4502C9.","volume":"50","author":"Lecoeur","year":"1996","journal-title":"Mol Pharmacol"},{"key":"R8-21-20250312","doi-asserted-by":"crossref","first-page":"237239","DOI":"10.1111\/j.0954-6820.1976.tb06724.x","article-title":"A nitrofurantoininduced disorder simulating chronic active hepatitis: a case report.","volume":"199","author":"Fagrell","year":"1976","journal-title":"Acta Med Scand"},{"key":"R9-21-20250312","doi-asserted-by":"crossref","first-page":"599606","DOI":"10.1002\/hep.1840080327","article-title":"Hepatic injury associated with the use of nitrofurans: a clinicopathological study of 52 reported cases.","volume":"8","author":"Stricker","year":"1988","journal-title":"HEPATOLOGY"},{"key":"R10-21-20250312","doi-asserted-by":"crossref","first-page":"169172","DOI":"10.1136\/bmj.312.7024.169","article-title":"Minocycline induced autoimmune hepatitis and systemic lupus erythematosuslike syndrome.","volume":"312","author":"Gough","year":"1996","journal-title":"BMJ"},{"key":"R11-21-20250312","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1097\/00004836-199807000-00016","article-title":"Minocyclineinduced hepatitis with autoimmune features and neutropenia.","volume":"27","author":"Bhat","year":"1998","journal-title":"J Clin Gastroenterol"},{"key":"R12-21-20250312","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.7326\/0003-4819-92-1-14","article-title":"Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin.","volume":"92","author":"Sharp","year":"1980","journal-title":"Ann Intern Med"},{"key":"R13-21-20250312","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.7326\/0003-4819-92-1-62","article-title":"Nitrofurantoininduced chronic active hepatitis.","volume":"92","author":"Black","year":"1980","journal-title":"Ann Intern Med"},{"key":"R14-21-20250312","doi-asserted-by":"crossref","first-page":"578582","DOI":"10.1016\/S0168-8278(97)80364-9","article-title":"Subfulminant hepatic failure in autoimmune hepatitis type 1: an unusual form of presentation.","volume":"27","author":"Herzog","year":"1997","journal-title":"J Hepatol"},{"key":"R15-21-20250312","doi-asserted-by":"crossref","first-page":"591598","DOI":"10.1309\/KV2J-VX6Q-L95V-VDE4","article-title":"Minocycline as a cause of druginduced autoimmune hepatitis: report of four cases and comparison with autoimmune hepatitis.","volume":"114","author":"Goldstein","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"R16-21-20250312","doi-asserted-by":"crossref","first-page":"333349","DOI":"10.2165\/00002018-200023040-00006","article-title":"Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data.","volume":"23","author":"Lawrenson","year":"2000","journal-title":"Drug Saf"},{"key":"R17-21-20250312","doi-asserted-by":"crossref","first-page":"169176","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis.","volume":"48","author":"Hennes","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R18-21-20250312","doi-asserted-by":"crossref","first-page":"14091417","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis: an update on terminology and reporting.","volume":"19","author":"Batts","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R19-21-20250312","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0140-6736(69)90921-0","article-title":"Hepatic reaction to nitrofurantoin.","volume":"2","author":"Bhagwat","year":"1969","journal-title":"Lancet"},{"key":"R20-21-20250312","first-page":"497502","article-title":"Nitrofurantoininduced chronic liver disease: clinical course and outcome of five cases.","volume":"14","author":"Iwarson","year":"1979","journal-title":"Scand J Gastroenterol"},{"key":"R22-21-20250312","doi-asserted-by":"crossref","first-page":"7779","DOI":"10.1136\/bmj.4.5988.77","article-title":"Trigger factors and HLA antigens in chronic active hepatitis.","volume":"4","author":"Lindberg","year":"1975","journal-title":"Br Med J"},{"key":"R23-21-20250312","doi-asserted-by":"crossref","first-page":"174175","DOI":"10.1136\/bmj.2.6028.174-b","article-title":"Letter: chronic active hepatitis induced by nitrofurantoin.","volume":"2","author":"Stromberg","year":"1976","journal-title":"Br Med J"},{"key":"R24-21-20250312","doi-asserted-by":"crossref","first-page":"117121","DOI":"10.1016\/0002-9343(79)90086-X","article-title":"Nitrofurantoin: another cause of druginduced chronic active hepatitis? A report of a patient with HLAB8 antigen.","volume":"67","author":"Hatoff","year":"1979","journal-title":"Am J Med"},{"key":"R25-21-20250312","doi-asserted-by":"crossref","first-page":"664668","DOI":"10.1053\/gast.1997.v113.pm9247489","article-title":"A novel histological lesion in glucocorticoidresponsive chronic hepatitis.","volume":"113","author":"Pratt","year":"1997","journal-title":"Gastroenterology"},{"key":"R26-21-20250312","doi-asserted-by":"crossref","first-page":"625631","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis.","volume":"2","author":"Kessler","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R27-21-20250312","doi-asserted-by":"crossref","first-page":"119121","DOI":"10.1016\/S1665-2681(19)31944-1","article-title":"Nitrofurantoininduced lung and hepatotoxicity.","volume":"6","author":"Koulaouzidis","year":"2007","journal-title":"Ann Hepatol"},{"key":"R28-21-20250312","doi-asserted-by":"crossref","first-page":"7985","DOI":"10.1111\/j.1365-2036.2007.03355.x","article-title":"Longterm followup of patients with mild to moderate druginduced liver injury.","volume":"26","author":"Bjornsson","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R29-21-20250312","first-page":"891893","article-title":"Longterm hepatic memory for hypersensitivity to nitrofurantoin.","volume":"87","author":"Paiva","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"R30-21-20250312","doi-asserted-by":"crossref","first-page":"11321136","DOI":"10.1001\/archpedi.152.11.1132","article-title":"Minocyclinerelated autoimmune hepatitis: case series and literature review.","volume":"152","author":"Teitelbaum","year":"1998","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R31-21-20250312","doi-asserted-by":"crossref","first-page":"787790","DOI":"10.1097\/MCG.0b013e31818c8801","article-title":"Longterm minocycline use for acne in healthy adolescents can cause severe autoimmune hepatitis.","volume":"43","author":"Ramakrishna","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"R32-21-20250312","doi-asserted-by":"crossref","first-page":"511517","DOI":"10.1016\/j.jhep.2008.10.021","article-title":"The longterm followup after idiosyncratic druginduced liver injury with jaundice.","volume":"50","author":"Bjornsson","year":"2009","journal-title":"J Hepatol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.23588","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201006000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T11:07:04Z","timestamp":1741777624000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201006000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.23588","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}